Drug Interaction Report
2 potential interactions and/or warnings found for the following 2 drugs:
- Adriamycin RDF (doxorubicin)
- galantamine
Interactions between your drugs
DOXOrubicin galantamine
Applies to: Adriamycin RDF (doxorubicin), galantamine
Galantamine can occasionally cause slowing of the heart rate or other irregular heart rhythm, and combining it with medications like DOXOrubicin may increase that risk. Talk to your doctor if you have any questions or concerns. Your doctor may be able to prescribe alternatives that do not interact, or you may need a dose adjustment or more frequent monitoring to safely use both medications. Contact your doctor if you develop dizziness, lightheadedness, fainting, shortness of breath, chest pain, or heart palpitations during treatment. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Drug and food interactions
galantamine food
Applies to: galantamine
Galantamine should be taken with food, and you should drink plenty of fluids throughout the day to reduce the severity of certain side effects such as nausea, vomiting, diarrhea, loss of appetite, and/or weight loss. Extended-release formulations should be swallowed whole (i.E., do not crush, chew, or divide the pill) and are often recommended to be taken in the morning. You should speak with your healthcare provider before using grapefruit products (fruit, juice, supplements) with galantamine as they may increase the blood levels and side effects of galantamine. You should also contact your healthcare provider if you experience changes in your heart rate, seizures, difficulty breathing, trouble urinating, dizziness, fainting, nausea, vomiting, diarrhea, and/or unexpected weight loss. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Therapeutic duplication warnings
No duplication warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Carvykti
Carvykti (ciltacabtagene autoleucel) is a treatment for relapsed or refractory multiple myeloma ...
Abecma
Abecma is a CAR T cell therapy used to treat relapsed refractory multiple myeloma (RRMM); it is a ...
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Tecvayli
Tecvayli (teclistamab) is a treatment for relapsed or refractory multiple myeloma. Includes ...
Verzenio
Verzenio is used to treat early and advanced-stage hormone receptor-positive, HER2-negative breast ...
Trodelvy
Trodelvy (sacituzumab govitecan) is a targeted therapy used to treat breast cancer (triple-negative ...
Enhertu
Enhertu is a treatment for breast cancer, stomach cancer, and non-small cell lung cancer with HER2 ...
Talvey
Talvey is used to treat relapsed or refractory multiple myeloma. Includes Talvey side effects ...
Kisqali
Kisqali (ribociclib) is used to treat a certain type of advanced metastatic breast cancer. Includes ...
Learn more
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.